Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines Read more
Invite from Justin Mason-Home, Chair at SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients 2021 Read more
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates Read more
Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK for the Advancement of Multiple Pre-Phase 2 Programs Read more
Valence Discovery to Support Repare Therapeutics on AI-Enabled Drug Discovery in Precision Oncology Read more
Hoth Therapeutics Partners with University of Cincinnati to Perform Critical Studies for Streamlined Development of Novel Antibiotic HT-006 Read more